Search

Negin Shojaee

from Lexington, MA
Age ~58
Get Report
Also known as:
Bijan Khosraviani, Bigan Khosraviani, Bijan Khosravyani, Shojaee Negin, Nagin Shojace, Bijan I, Negin E
Phone and address:
11 Woodcliffe Rd, Lexington, MA 02421
Related to:
Behrooz KhosravianiBijan KhosravianiNima Shojaee, 53Sima M Rohani, 65Avishan Khosravyani, 33
Connected to:
Farzad Shojaei, 51Maryam Shojaei, 49Mehrdad Shojaei, 59Mohsen K Shojaei, 63Seyedeh Shojaei, 42Annemarie W Shojai, 56Tracie M Shojai, 59Ali Shojania, 65Abe Shoji, 98Debra K Shoji, 42

Negin Shojaee Phones & Addresses

  • 11 Woodcliffe Rd, Lexington, MA 02421
  • Somerville, MA
  • Cupertino, CA
  • San Jose, CA
  • 240 Broadway, Arlington, MA 02174 (781) 643-7167
  • 215 Massachusetts Ave, Arlington, MA 02474
  • Palo Alto, CA

Work

Company: Pfizer Jan 2016 Position: Associate director clinical scientist at pfizer

Education

Degree: Doctorates, Doctor of Philosophy School / High School: Boston University 1994 to 1999 Specialities: Biology

Skills

Clinical Development • Clinical Research • Clinical Trials • Biotechnology • Pharmaceutical Industry • Drug Discovery • Oncology • Cro • Ctms • Immunology • Drug Development • Fda • Gcp • Lifesciences • Elisa • Angiogenesis • Bioinformatics • Vascular • Cro Management • Vascular Biology • Respiratory Disease

Industries

Pharmaceuticals

Public records

Vehicle Records

Negin Shojaee

View page
Address:
90 Palmer St, Arlington, MA 02474
Phone:
(408) 891-2759
VIN:
5UXFE43508L003225
Make:
BMW
Model:
X5
Year:
2008

Resumes

Resumes

Negin Shojaee Photo 1

Associate Director Clinical Scientist At Pfizer

View page
Location:
400 Crossing Blvd, Bridgewater, NJ 08807
Industry:
Pharmaceuticals
Work:
Pfizer
Associate Director Clinical Scientist at Pfizer
Pfizer 2005 - May 2010
Clinical Scientist, Assistant Director
Pfizer 2000 - 2002
Senior Scientist
Boston University 1992 - 1994
Reasearch Assistant
Education:
Boston University 1994 - 1999
Doctorates, Doctor of Philosophy, Biology University Lille 1 1985 - 1991
Master of Science, Masters, Bachelors, Bachelor of Science, Biochemistry University of Lille 1 Sciences and Technology 1985 - 1991
Master of Science, Masters, Bachelors, Bachelor of Science, Biochemistry
Skills:
Clinical Development
Clinical Research
Clinical Trials
Biotechnology
Pharmaceutical Industry
Drug Discovery
Oncology
Cro
Ctms
Immunology
Drug Development
Fda
Gcp
Lifesciences
Elisa
Angiogenesis
Bioinformatics
Vascular
Cro Management
Vascular Biology
Respiratory Disease

Publications

Us Patents

Composition And Method For Treating Lupus Nephritis

View page
US Patent:
7491513, Feb 17, 2009
Filed:
Feb 15, 2006
Appl. No.:
11/355297
Inventors:
Margot O'Toole - Newton MA, US
William Martin Mounts - Andover MA, US
Negin Shojaee - San Jose CA, US
Assignee:
Wyeth - Madison NJ
International Classification:
C12P 21/02
C07H 21/04
US Classification:
435 691, 4353201, 435328, 536 235, 530350
Abstract:
The present invention provides novel isolated BFLP0169 polynucleotides and polypeptides encoded by the BFLP0169 polynucleotides. Also provided are the antibodies that immunospecifically bind to a BFLP0169 polypeptide or any derivative (including fusion derivative), variant, mutant or fragment of the BFLP0169 polypeptide, polynucleotide or antibody. The invention additionally provides methods in which the BFLP0169 polypeptide, polynucleotide and antibody are utilized in the detection and treatment of a broad range of pathological states, as well as to other uses.

Composition And Method For Treating Lupus Nephritis

View page
US Patent:
7667020, Feb 23, 2010
Filed:
Apr 17, 2007
Appl. No.:
11/787715
Inventors:
Margot O'Toole - Newton MA, US
William Martin Mounts - Andover MA, US
Negin Shojaee - San Jose CA, US
Assignee:
Wyeth - Madison NJ
International Classification:
C07H 21/00
C12Q 1/68
C12P 21/06
US Classification:
536 235, 435 6, 435 691
Abstract:
The present invention provides novel isolated BFLP1698 polynucleotides and polypeptides encoded by the BFLP1698 polynucleotides. Also provided are the antibodies that immunospecifically bind to a BFLP1698 polypeptide or any derivative (including fusion derivative), variant, mutant or fragment of the BFLP1698 polypeptide, polynucleotide or antibody. The invention additionally provides methods in which the BFLP1698 polypeptide, polynucleotide and antibody are utilized in the detection and treatment of a broad range of pathological states, as well as to other uses.

Composition And Method For Treating Lupus Nephritis

View page
US Patent:
20040209284, Oct 21, 2004
Filed:
Nov 21, 2003
Appl. No.:
10/719385
Inventors:
Margot O'Toole - Newton MA, US
William Mounts - Andover MA, US
Negin Shojaee - Palo Alto CA, US
International Classification:
C12Q001/68
C07H021/04
C07K014/705
US Classification:
435/006000, 435/069100, 435/320100, 435/325000, 530/350000, 536/023500
Abstract:
The present invention provides novel isolated BFLP0169 polynucleotides and polypeptides encoded by the BFLP0169 polynucleotides. Also provided are the antibodies that immunospecifically bind to a BFLP0169 polypeptide or any derivative (including fusion derivative), variant, mutant or fragment of the BFLP0169 polypeptide, polynucleotide or antibody. The invention additionally provides methods in which the BFLP0169 polypeptide, polynucleotide and antibody are utilized in the detection and treatment of a broad range of pathological states, as well as to other uses.

Composition And Method For Treating Lupus Nephritis

View page
US Patent:
20050119208, Jun 2, 2005
Filed:
Nov 21, 2003
Appl. No.:
10/718834
Inventors:
Margot O'Toole - Newton MA, US
William Mounts - Andover MA, US
Negin Shojaee - San Jose CA, US
International Classification:
A61K048/00
C07H021/04
A61K039/395
US Classification:
514044000, 424131100, 536023500, 435069100, 435320100, 435327000, 530387200, 435006000, 435007200
Abstract:
The present invention provides novel isolated BFLP1698 polynucleotides and polypeptides encoded by the BFLP1698 polynucleotides. Also provided are the antibodies that immunospecifically bind to a BFLP1698 polypeptide or any derivative (including fusion derivative), variant, mutant or fragment of the BFLP1698 polypeptide, polynucleotide or antibody. The invention additionally provides methods in which the BFLP1698 polypeptide, polynucleotide and antibody are utilized in the detection and treatment of a broad range of pathological states, as well as to other uses.

Composition And Method For Treating Lupus Nephritis

View page
US Patent:
20090098132, Apr 16, 2009
Filed:
Sep 23, 2008
Appl. No.:
12/235674
Inventors:
Margot O'Toole - Newton MA, US
William Martin Mounts - Andover MA, US
Negin Shojaee - San Jose CA, US
Assignee:
Wyeth - Madison NJ
Genetics Institute, LLC - Cambridge MA
International Classification:
A61K 39/395
C12N 15/11
C12N 15/00
C12N 1/21
C12N 5/06
C12N 1/19
C07K 14/00
A61K 38/02
C07K 16/18
C12P 21/04
C12Q 1/68
G01N 33/566
US Classification:
4241391, 536 231, 4353201, 43525233, 435348, 4352542, 435358, 435365, 530350, 514 12, 5303879, 5303873, 435 697, 435 6, 436501
Abstract:
The present invention provides novel isolated BFLP0169 polynucleotides and polypeptides encoded by the BFLP0169 polynucleotides. Also provided are the antibodies that immunospecifically bind to a BFLP0169 polypeptide or any derivative (including fusion derivative), variant, mutant or fragment of the BFLP0169 polypeptide, polynucleotide or antibody. The invention additionally provides methods in which the BFLP0169 polypeptide, polynucleotide and antibody are utilized in the detection and treatment of a broad range of pathological states, as well as to other uses.
Control profile
Negin Shojaee from Lexington, MA, age ~58 Get Report